Anticipating and managing the cutaneous side effects of epidermal growth factor receptor inhibitors
Author:
Affiliation:
1. Epworth Hospital; Melbourne Victoria Australia
2. University of Melbourne; Melbourne Victoria Australia
Publisher
Wiley
Subject
Oncology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.12160/fullpdf
Reference12 articles.
1. Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial;Vincenzi;Br J Cancer,2006
2. Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor;Saltz;J Clin Oncol,2004
3. Panitumumab monotherapy in patients with previously treated metastatic colorectal cancer;Hecht;Cancer,2007
4. Skin toxicities in targeted therapies;Segaert;Eur J Cancer,2009
5. Challenges in the use of epidermal growth factor receptor inhibitors in colorectal cancer;Van Cutsem;Oncologist,2006
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Preclinical Pharmacokinetics and Biodistribution of LR004, a Novel Antiepidermal Growth Factor Receptor Monoclonal Antibody;Molecules;2024-01-22
2. Management of Apatinib-Related Adverse Events in Patients With Advanced Osteosarcoma From Four Prospective Trials: Chinese Sarcoma Study Group Experience;Frontiers in Oncology;2021-07-22
3. Clinical experience of chinese herbal medicine ameliorates dermatologic events from epidermal growth factor receptor inhibitors for lung cancer: A case series;EXPLORE;2019-09
4. Cetuximab Induced Acneiform Eruption, Telangiectasia, Hypertrichosis, Paronychia, and Digital Fissures: a Case Report;Turkish Journal of Dermatology;2019-03-01
5. Topical doxycycline foam 4% for prophylactic management of epidermal growth factor receptor inhibitor skin toxicity: an exploratory phase 2, randomized, double-blind clinical study;Supportive Care in Cancer;2019-01-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3